Monoclonal antibodies in cancer therapy

被引:12
作者
Gruber, R
Holz, E
Riethmuller, G
机构
[1] UNIV MUNICH, INST IMMUNOL, D-80336 MUNICH, GERMANY
[2] UNIV MUNICH, FAK MED, TUMOR ZENTRUM MUNCHEN, D-80336 MUNICH, GERMANY
[3] TECH UNIV MUNICH, D-8000 MUNICH, GERMANY
来源
SPRINGER SEMINARS IN IMMUNOPATHOLOGY | 1996年 / 18卷 / 02期
关键词
D O I
10.1007/BF00820669
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:243 / 251
页数:9
相关论文
共 59 条
[1]  
ASANO M, 1995, CANCER RES, V55, P5296
[2]   RECEPTOR BLOCKADE WITH MONOCLONAL-ANTIBODIES AS ANTICANCER THERAPY [J].
BASELGA, J ;
MENDELSOHN, J .
PHARMACOLOGY & THERAPEUTICS, 1994, 64 (01) :127-154
[3]   ANTITUMOR EFFECTS OF DOXORUBICIN IN COMBINATION WITH ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODIES [J].
BASELGA, J ;
NORTON, L ;
MASUI, H ;
PANDIELLA, A ;
COPLAN, K ;
MILLER, WH ;
MENDELSOHN, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (16) :1327-1333
[4]   Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast [J].
Baselga, J ;
Tripathy, D ;
Mendelsohn, J ;
Baughman, S ;
Benz, CC ;
Dantis, L ;
Sklarin, NT ;
Seidman, AD ;
Hudis, CA ;
Moore, J ;
Rosen, PP ;
Twaddell, T ;
Henderson, IC ;
Norton, L .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :737-744
[5]  
BASELGA J, 1994, ANN ONCOL S5, V5
[6]   SIGNIFICANCE OF ANGIOGENESIS IN TUMOR PROGRESSION AND METASTASIS [J].
BIKFALVI, A .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (7-8) :1101-1104
[7]  
CARON PC, 1995, CLIN CANCER RES, V1, P63
[8]  
CHARNOW SM, 1996, TRENDS BIOTECHNOL, V14, P52
[9]   CLINICAL ISSUES IN ANTIBODY DESIGN [J].
CHESTER, KA ;
HAWKINS, RE .
TRENDS IN BIOTECHNOLOGY, 1995, 13 (08) :294-300
[10]   APOPTOTIC CELL-DEATH INDUCED BY A MOUSE-HUMAN ANTI-APO-1 CHIMERIC ANTIBODY LEADS TO TUMOR-REGRESSION [J].
CONEY, LR ;
DANIEL, PT ;
SANBORN, D ;
DHEIN, J ;
DEBATIN, KM ;
KRAMMER, PH ;
ZURAWSKI, VR .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (04) :562-567